Methods and devices for analyzing species to determine diseases
US-2024264160-A1 · Aug 8, 2024 · US
Method of judging risk of cancer recurrence and computer program
US9146239B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9146239-B2 |
| Application number | US-201213682377-A |
| Country | US |
| Kind code | B2 |
| Filing date | Nov 20, 2012 |
| Priority date | Nov 29, 2011 |
| Publication date | Sep 29, 2015 |
| Grant date | Sep 29, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
There is provided a method of judging a risk of cancer recurrence based on the activity value and expression level of the first CDK, the activity value and expression level of the second CDK, and the expression levels of uPA and PAI-1 and a computer program.
First claim
Opening claim text (preview).
What is claimed is: 1. A method of judging a risk of cancer recurrence comprising a step of: acquiring an activity value and expression level of a first cyclin-dependent-kinase (CDK), an activity value and expression level of a second CDK, an expression level of urokinase plasminogen activator (uPA), and an expression level of plasminogen activator inhibitor 1 (PAI-1) from biological samples extracted from cancer patients; judging a risk of cancer recurrence using at least one…
Assignees
Inventors
Classifications
Physics · mapped topic
- G01N33/57595Primary
Physics · mapped topic
Physics · mapped topic
Physics · mapped topic
Physics · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9146239B2 cover?
- There is provided a method of judging a risk of cancer recurrence based on the activity value and expression level of the first CDK, the activity value and expression level of the second CDK, and the expression levels of uPA and PAI-1 and a computer program.
- Who is the assignee on this patent?
- Sysmex Corp
- What technology area does this patent fall under?
- Primary CPC classification G01N33/57595. Mapped technology areas include Physics.
- When was this patent published?
- Publication date Tue Sep 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).